JUN and central nervous system cancer: JUN expression can be applied to predict survival outcome, and high JUN expression indicates worse survival outcome in GBM (P = 001, Supplementary Figure S3B) and glioma (P = 0.026, Supplementary Figure S3C) based on the TCGA sequence database.